Business and people search

Epistem in £4.3m placing

Epistem's Genedrive device
Epistem's Genedrive device
James Graham
James Graham
Deputy Editor, North West

MANCHESTER diagnostics firm Epistem is to raise £4.3m to support the commercial launch of its main product, the Genedrive.The AIM-listed business is placing 793,398 ordinary shares with new and existing investors at £5.45 a share, a 4% discount to the closing price of £5.67 on December 6.Epistem's Genedrive is a machine which uses molecular diagnosis to provide a rapid test which can highlight a range of conditions within 30 minutes.It plans to use the cash to support the use of the device for tuberculosis testin... for the full story register now for free or login below...

Login to Read this Story


Latest Business News

 
TheBusinessDesk is a trading name of Regional Media Services Ltd.
A company registered in the UK, company number : 07111349 VAT Number : 124302954
Close